GGrantIndex
← Leaderboards

Robia G Pautler

Carnegie-Mellon University

Google Scholar ↗PubMed ↗ORCID ↗
$6,804,159
Attributed
$9,887,826
Total exposure
12
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,887,826 · 12

By mechanism

R01$6,387,054 · 4
R21$1,181,103 · 3
P41$764,841 · 2
R56$730,015 · 1
S10$600,000 · 1
R41$224,813 · 1

Top collaborators

Most similar at Carnegie-Mellon University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposMagnetic Resonance ImagingMouse ModelIn VivoImageBaseInnovationPropertyMissionMonitorAnimalsDiagnosticHyperphosphorylated TauDepositionTreatment EfficacyNeurodegenerative DisordersResponseNeurofibrillary TanglesS DiseaseTau ProteinsAmyloid Beta-ProteinBehavioralBiochemistryNeurons

Grant awards (27)

Incorporating Spatial Proteomics to Understand the Basis of Hyper and Hypoconnectivity in mouse models of AD$766,795
R01 · FY2025 · AG · contact PI
Enabling systemic delivery of europium-containing contrast agents for magnetic resonance imaging$578,863
R01 · FY2025 · EB
Incorporating Spatial Proteomics to Understand the Basis of Hyper and Hypoconnectivity in mouse models of AD$782,443
R01 · FY2024 · AG · contact PI
Delaying Alzheimer's Disease Progression Through Intranasally Administered Nano-Antioxidants$730,015
R56 · FY2021 · AG · contact PI
Intratumoral imaging of hypoxia using 1H- and 19F-MRI with redox-responsive Eu-based contrast agents$656,139
R01 · FY2021 · EB
Intratumoral imaging of hypoxia using 1H- and 19F-MRI with redox-responsive Eu-based contrast agents$676,601
R01 · FY2020 · EB
Intratumoral imaging of hypoxia using 1H- and 19F-MRI with redox-responsive Eu-based contrast agents$683,300
R01 · FY2019 · EB
Intratumoral imaging of hypoxia using 1H- and 19F-MRI with redox-responsive Eu-based contrast agents$703,151
R01 · FY2018 · EB
9.4T MRI Upgrade$600,000
S10 · FY2018 · OD · contact PI
Mitochondrial Targeted Nano-antioxidants to Treat Alzheimer's Disease$224,813
R41 · FY2017 · AG · contact PI
MANGANESE ENHANCED MRI: NON-INVASIVE MEASURE OF PATHOGENESIS OF DYSTROPHINOPATHY$195,625
R21 · FY2015 · NS
MANGANESE ENHANCED MRI: NON-INVASIVE MEASURE OF PATHOGENESIS OF DYSTROPHINOPATHY$218,020
R21 · FY2014 · NS
Nano-Antioxidants as a Therapeutic for Preclinical Models of NAFLD$221,186
R21 · FY2013 · DK · contact PI
Neuroimaging Biomarkers in Mouse Models of AD$299,442
R01 · FY2012 · AG · contact PI
Nano-Antioxidants as a Therapeutic for Preclinical Models of NAFLD$204,288
R21 · FY2012 · DK · contact PI
Neuroimaging Biomarkers in Mouse Models of AD$299,442
R01 · FY2011 · AG · contact PI
Neuroimaging Biomarkers in Mouse Models of AD$311,528
R01 · FY2010 · AG · contact PI
Neuroimaging Biomarkers in Mouse Models of AD$314,675
R01 · FY2009 · AG · contact PI
Neuroimaging Biomarkers in Mouse Models of AD$314,675
R01 · FY2008 · AG · contact PI
MRI Determination of Axonal Transport Rates in Mouse CNS$203,234
R21 · FY2006 · NS · contact PI
MRI Determination of Axonal Transport Rates in Mouse CNS$138,750
R21 · FY2005 · NS
MANGANESE AS CONTRAST AGENT FOR MRI OF BRAIN ACTIVATION &NEURONAL TRACT TRACING$134,676
P41 · FY2002 · RR
PERFUSION IMAGING OF BRAIN, KIDNEY, &HEART$134,676
P41 · FY2002 · RR
MANGANESE AS CONTRAST AGENT FOR MRI OF BRAIN ACTIVATION &NEURONAL TRACT TRACING$134,676
P41 · FY2001 · RR
PERFUSION IMAGING OF BRAIN, KIDNEY, &HEART$134,676
P41 · FY2001 · RR
PERFUSION IMAGING OF BRAIN, KIDNEY, &HEART$146,243
P41 · FY2000 · RR
MANGANESE AS CONTRAST AGENT FOR MRI OF BRAIN ACTIVATION &NEURONAL TRACT TRACING$79,894
P41 · FY2000 · RR